BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10189025)

  • 1. Recurrence of gynecologic malignancy at the vaginal vault after hysterectomy.
    Heller DS; Kambham N; Smith D; Cracchiolo B
    Int J Gynaecol Obstet; 1999 Feb; 64(2):159-62. PubMed ID: 10189025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is cytologic screening an effective surveillance method for detection of vaginal recurrence of uterine cancer?
    Cooper AL; Dornfeld-Finke JM; Banks HW; Davey DD; Modesitt SC
    Obstet Gynecol; 2006 Jan; 107(1):71-6. PubMed ID: 16394042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal fine-needle aspiration: A useful alternative to biopsy.
    Lin DM; Barkan GA; Chatt G; Park JW; Gattuso P
    Diagn Cytopathol; 2016 Aug; 44(8):665-9. PubMed ID: 27220040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR appearance of the normal and abnormal vagina after hysterectomy.
    Brown JJ; Gutierrez ED; Lee JK
    AJR Am J Roentgenol; 1992 Jan; 158(1):95-9. PubMed ID: 1727367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The salvage of recurrent endometrial carcinoma in the vagina and pelvis.
    Poulsen MG; Roberts SJ
    Int J Radiat Oncol Biol Phys; 1988 Oct; 15(4):809-13. PubMed ID: 3182320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Local injection of cisplatin for vaginal stump recurrence of gynecological malignant tumor].
    Sato Y; Igarashi S; Kushima T; Tanaka T
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):409-12. PubMed ID: 9492836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Secondary vaginal adenocarcinoma: a clinicopathologic study of 55 cases].
    Zhou XR; Du XG
    Zhonghua Fu Chan Ke Za Zhi; 1994 May; 29(5):289-91, 318. PubMed ID: 7956554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of the impact of pathology review in gynecologic cancer.
    Chafe S; Honore L; Pearcey R; Capstick V
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1433-8. PubMed ID: 11121644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. True incidence of vaginal vault prolapse. Thirteen years of experience.
    Marchionni M; Bracco GL; Checcucci V; Carabaneanu A; Coccia EM; Mecacci F; Scarselli G
    J Reprod Med; 1999 Aug; 44(8):679-84. PubMed ID: 10483537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gynecologic cancers: factors affecting survival after pulmonary metastasectomy.
    Clavero JM; Deschamps C; Cassivi SD; Allen MS; Nichols FC; Barrette BA; Larson DR; Pairolero PC
    Ann Thorac Surg; 2006 Jun; 81(6):2004-7. PubMed ID: 16731120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginal recurrences of endometrial carcinoma: the prognostic value of staging by a primary vaginal carcinoma system.
    Curran WJ; Whittington R; Peters AJ; Fanning J
    Int J Radiat Oncol Biol Phys; 1988 Oct; 15(4):803-8. PubMed ID: 3182319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrences and metastases in carcinoma of the uterine body correlated to the size and localization of the primary tumor.
    Johnsson JE
    Acta Obstet Gynecol Scand; 1979; 58(4):405-8. PubMed ID: 525276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endolymphatic stromal myosis of the uterus with metastasis to ovary and recurrence in vagina.
    Yu TJ; Iwasaki I; Horie H; Tamaru J; Takahashi A
    Acta Pathol Jpn; 1986 Feb; 36(2):301-8. PubMed ID: 3705963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal Morcellation Inside Protective Pouch: A Safe Strategy for Uterine Extration in Cases of Bulky Endometrial Cancers: Operative and Oncological Safety of the Method.
    Favero G; Miglino G; Köhler C; Pfiffer T; Silva e Silva A; Ribeiro A; Le X; Anton C; Baracat EC; Carvalho JP
    J Minim Invasive Gynecol; 2015; 22(6):938-43. PubMed ID: 25917277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local recurrence in high-risk node-negative stage I endometrial carcinoma treated with postoperative vaginal vault brachytherapy.
    Ng TY; Perrin LC; Nicklin JL; Cheuk R; Crandon AJ
    Gynecol Oncol; 2000 Dec; 79(3):490-4. PubMed ID: 11104626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of vault cytology in follow-up of hysterectomized women: results and inferences from a low resource setting.
    Gupta S; Sodhani P; Singh V; Sehgal A
    Diagn Cytopathol; 2013 Sep; 41(9):762-6. PubMed ID: 23288466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of Occult Uterine Malignancy Following Vaginal Hysterectomy With Morcellation.
    Wasson M; Magtibay P; Magtibay P; Magrina J
    J Minim Invasive Gynecol; 2017; 24(4):665-669. PubMed ID: 28254678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evolution of malignant mixed müllerian tumor.
    Chang WW; Boyd CB; Ashraf M
    Diagn Gynecol Obstet; 1980; 2(4):257-63. PubMed ID: 6260440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Single vaginal vault recurrences following endometrial carcinoma stage 1 treated by operation (author's transl)].
    Litschgi M
    Geburtshilfe Frauenheilkd; 1979 Apr; 39(4):300-3. PubMed ID: 437469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance for recurrent cancers and vaginal epithelial lesions in patients with invasive cervical cancer after hysterectomy: are vaginal cytology and high-risk human papillomavirus testing useful?
    Li Z; Barron S; Hong W; Karunamurthy A; Zhao C
    Am J Clin Pathol; 2013 Nov; 140(5):708-14. PubMed ID: 24124151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.